Bart Barlogie

76.5k citations
706 papers · 42.7k · 9 hit papers · h-index 110

Impact in

  • Hematology top 0.01%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 0.02%
    • Peptidase Inhibition and Analysis
    • Cancer Treatment and Pharmacology

Papers in

    • Multiple Myeloma Research and Treatments 541
    • Hematopoietic Stem Cell Transplantation 48
    • Acute Myeloid Leukemia Research 39
    • Protein Degradation and Inhibitors 133
    • Cancer therapeutics and mechanisms 52

Bart Barlogie

675 papers receiving 41.6k citations

Bart Barlogie's Hit Papers

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial 2016 · 612 citations
6120+14+28Years since publication50010001.5k

Peers

Bart Barlogie
Comparison fields: 5 of 167
  • Hematology 29.5k
  • Oncology 15.3k
  • Genetics 4.7k
  • Molecular Biology 21.3k
  • Immunology 3.6k
Replace Paul G. Richardson with:
Paul G. Richardson United States
Shaji Kumar United States
Angela Dispenzieri United States
Philip R. Greipp United States
Rafaël Fonseca United States
Pieter Sonneveld Netherlands
Morie A. Gertz United States
Guido Tricot United States
Martin S. Tallman United States
Nikhil C. Munshi United States
Bart Barlogie relative to Paul G. Richardson United States Paul G. Richardson's profile →
Citations per field
00.5×1.5×
Paul G. Richardson · 1×
Citations per year

Countries citing papers authored by Bart Barlogie

Since Specialization
Citations

This map shows the geographic impact of Bart Barlogie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Barlogie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Barlogie more than expected).

Fields of papers citing papers by Bart Barlogie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Barlogie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Barlogie. The network helps show where Bart Barlogie may publish in the future.

Co-authors

The 25 scholars most cited alongside Bart Barlogie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart Barlogie Line = papers co-authored together Bart Barlogie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 706 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International Staging System for Multiple Myeloma
Hit paper breakdown →
20051978
2
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Hit paper breakdown →
19991972
3
The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma
Hit paper breakdown →
20031128
4
The molecular classification of multiple myeloma
Hit paper breakdown →
2006789
5
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2016612
6
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
Hit paper breakdown →
2004569
7
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Hit paper breakdown →
2006535
8
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
Hit paper breakdown →
2002508
9
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Hit paper breakdown →
1984502
10 2005487
11 2004487
12 2006483
13 2001418
14 1996418
15 1997414
16 1999370
17 2001366
18 1995360
19 2003360
20 1993358

About Bart Barlogie

Bart Barlogie is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 706 papers that have together received 42.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (541 papers), Protein Degradation and Inhibitors (133 papers), Cancer Treatment and Pharmacology (98 papers), Peptidase Inhibition and Analysis (71 papers), Chronic Lymphocytic Leukemia Research (53 papers), Cancer therapeutics and mechanisms (52 papers), Hematopoietic Stem Cell Transplantation (48 papers) and Acute Myeloid Leukemia Research (39 papers). The work is most often cited by research in Hematology (29.5k citations), Oncology (15.3k citations), Genetics (4.7k citations), Molecular Biology (21.3k citations) and Immunology (3.6k citations). Bart Barlogie has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include John D. Shaughnessy, Guido Tricot, John Crowley, Elias Anaissie, Joshua Epstein, Frits van Rhee, Maurizio Zangari, Sundar Jagannath, Fenghuang Zhan and Nikhil C. Munshi. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact